Some patients with unresectable hepatocellular carcinoma (HCC) have prolonged survival after treatment with yttrium-90 radioembolization. Researchers conducted a study to analyze which factors can help predict “Super Survivor” outcomes, which were defined as surviving 3 or more years after Y-90… Read More
Patients with unresectable intrahepatic cholangiocarcinoma (ICC) can benefit from transarterial ytrrium-90 (Y-90) glass microsphere radioembolization, according to a study published in the Journal of Vascular and Interventional Radiology. ICC frequently is asymptomatic, and, as a result, many… Read More
Researchers have found that stable and unstable water-in-oil (W/O) emulsions are equally effective for chemoembolization, though stable emulsions lead to less myelosuppression and a more favorable pharmacokinetic profile. The types of ethiodized oil emulsions or mixing steps have not been… Read More
Patients with caudate hepatocellular carcinoma (HCC) within the Milan criteria may experience better results with radiofrequency ablation (RFA) than with transarterial chemoembolization (TACE), according to a study published in Cardiovascular and Interventional Radiology. Although HCC in the… Read More
The combination of sorafenib and transarterial chemoembolization (TACE) for patients with advanced hepatocellular carcinoma (HCC) seems feasible and promising, researchers reported. Phase III trials have not shown a clinical benefit of the combined therapy, but there have been signs of promise in… Read More
Percutaneous cryoblation ablation may be a reasonable treatment option for patients with clinical stage T1a papillary on renal cell carcinoma (pRCC) and clear-cell RCC (ccRCC), especially for patients with (pRCC). For the study, researchers used a single institution’s renal ablation registry to… Read More
The combination of microwave ablation and cementoplasty may offer patients with extra-spinal metastases a minimally invasive option for pain reduction. The combined microwave ablation and cementoplasty treatment was safe and effective, according to an abstract presented at the World Conference on… Read More
HCC cells
Inhibition of cancer stem cells in hepatocellular carcinoma (HCC) may improve the efficacy of percutaneous thermal ablation, transarterial chemoembolization (TACE), and transarterial embolization (TAE), according to an abstract presented at the World Conference on Interventional Oncology. Patients… Read More
Primary left-side colorectal cancer and a tumor size ≤ 3 cm were found to independently predict better oncologic outcomes for patients undergoing radiofrequency ablation (RFA) outcome in colorectal liver metastases. Researchers undertook the retrospective study to evaluate whether a primary tumor… Read More
liver cancer
An analysis of 9 studies has concluded that transarterial chemoembolization (TACE) plus iodine-125 seed results in better clinical outcomes than TACE alone for patients with hepatocellular carcinoma (HCC). TACE is a recommended effective treatment for patients with advanced HCC, and recent… Read More